ArticleEvolution, medicine, and public health2013
Hygiene and the world distribution of Alzheimer's disease: Epidemiological evidence for a relationship between microbial environment and age-adjusted disease burden.
Article in Evolution, medicine, and public health, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 51 citations in OpenAlex.
- Advances in Autophagy-Lysosomal Pathway and Neurodegeneration via Brain-Gut Axis.Biomedicines · 2025Review
- Article
- Review
- A short history from Karelia study to biodiversity and public health interventions.Frontiers in allergy · 2023Review
- Digoxin Exhibits Neuroprotective Properties in a Rat Model of Dementia.Neurochemical research · 2022Article
- Role of environmental pollutants in Alzheimer's disease: a review.Environmental science and pollution research international · 2020Review
- How do Rural Second Homes Affect Human Health and Well-being? Review of Potential Impacts.International journal of environmental research and public health · 2020Review
- Evidence against a geographic gradient of Alzheimer's disease and the hygiene hypothesis.Evolution, medicine, and public health · 2020Article
- Gut Microbiota in Neurological Disorders.Archivum immunologiae et therapiae experimentalis · 2019Review
- Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective.Annals of the New York Academy of Sciences · 2019Review
- Measuring the Brain-Gut Axis in Psychological Sciences: A Necessary Challenge.Frontiers in integrative neuroscience · 2019Article
- Gut microbiota in common elderly diseases affecting activities of daily living.World journal of gastroenterology · 2018Review
- 'Evolutionary medicine' perspectives on Alzheimer's Disease: Review and new directions.Ageing research reviews · 2018Review
- Spinal cord injury and Alzheimer's disease risk: a population-based, retrospective cohort study.Spinal cord · 2018Article
- The Exceptional Vulnerability of Humans to Alzheimer's Disease.Trends in molecular medicine · 2017Review
- Transforming Life: A Broad View of the Developmental Origins of Health and Disease Concept from an Ecological Justice Perspective.International journal of environmental research and public health · 2016Article
- Glove wearing: an assessment of the evidence.British dental journal · 2015Article
- Role of environmental contaminants in the etiology of Alzheimer's disease: a review.Current Alzheimer research · 2015Review
- Alzheimer's Disease: Exploring the Role of Inflammation and Implications for Treatment.International journal of Alzheimer's disease · 2015Review
- Why medical community should take biodiversity loss seriously?Porto biomedical journalReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesAlzheimer's disease (AD) shares certain etiological features with autoimmunity. Prevalence of autoimmunity varies between populations in accordance with variation in environmental microbial diversity. Exposure to microorganisms may improve individuals' immunoregulation in ways that protect against autoimmunity, and we suggest that this may also be the case for AD. Here, we investigate whether differences in microbial diversity can explain patterns of age-adjusted AD rates between countries. METHODOLOGY: We use regression models to test whether pathogen prevalence, as a proxy for microbial diversity, across 192 countries can explain a significant amount of the variation in age-standardized AD disability-adjusted life-year (DALY) rates. We also review and assess the relationship between pathogen prevalence and AD rates in different world populations.
resultsBased on our analyses, it appears that hygiene is positively associated with AD risk. Countries with greater degree of sanitation and lower degree of pathogen prevalence have higher age-adjusted AD DALY rates. Countries with greater degree of urbanization and wealth exhibit higher age-adjusted AD DALY rates. CONCLUSIONS AND IMPLICATIONS: Variation in hygiene may partly explain global patterns in AD rates. Microorganism exposure may be inversely related to AD risk. These results may help predict AD burden in developing countries where microbial diversity is rapidly diminishing. Epidemiological forecasting is important for preparing for future healthcare needs and research prioritization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.